相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Symptomatic Toxicities Experienced During Anticancer Treatment: Agreement Between Patient and Physician Reporting in Three Randomized Trials
Massimo Di Maio et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
PROceeding With the Patient-Reported Outcomes (PROs) Version of the Common Terminology Criteria for Adverse Events
Benjamin Movsas
JAMA ONCOLOGY (2015)
Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
Amylou C. Dueck et al.
JAMA ONCOLOGY (2015)
COMPliance and Arthralgia in Clinical Therapy: the COMPACT trial, assessing the incidence of arthralgia, and compliance within the first year of adjuvant anastrozole therapy
P. Hadji et al.
ANNALS OF ONCOLOGY (2014)
Patients' self-assessment versus investigators' evaluation in a phase III trial in non-castrate metastatic prostate cancer (GETUG-AFU 15)
Gwenaelle Gravis et al.
EUROPEAN JOURNAL OF CANCER (2014)
Recommended Patient-Reported Core Set of Symptoms to Measure in Adult Cancer Treatment Trials
Bryce B. Reeve et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
Ethan Basch et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Cognitive interviewing of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
Jennifer L. Hay et al.
QUALITY OF LIFE RESEARCH (2014)
Recommendations for Incorporating Patient-Reported Outcomes Into Clinical Comparative Effectiveness Research in Adult Oncology
Ethan Basch et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis
Srdan Verstovsek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Reliability of adverse symptom event reporting by clinicians
Thomas M. Atkinson et al.
QUALITY OF LIFE RESEARCH (2012)
Use of Patient-Reported Outcomes to Improve the Predictive Accuracy of Clinician-Reported Adverse Events
Ethan Basch et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Stakeholder perspectives on implementing the National Cancer Institute's patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
Deborah Watkins Bruner et al.
TRANSLATIONAL BEHAVIORAL MEDICINE (2011)
Adding The Patient Perspective To Comparative Effectiveness Research
Albert W. Wu et al.
HEALTH AFFAIRS (2010)
The Missing Voice of Patients in Drug-Safety Reporting
Ethan Basch
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Clinician versus nurse symptom reporting using the National Cancer Institute-Common Terminology Criteria for Adverse Events during chemotherapy: results of a comparison based on patient's self-reported questionnaire
M. Cirillo et al.
ANNALS OF ONCOLOGY (2009)
Patient Adherence and Persistence With Oral Anticancer Treatment
Kathryn Ruddy et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Optimal recall periods for patient-reported outcomes: challenges and potential solutions
Donald E. Stull et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Adverse Symptom Event Reporting by Patients vs Clinicians: Relationships With Clinical Outcomes
Ethan Basch et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Patient-reported outcomes and the evolution of adverse event reporting in oncology
Andy Trotti et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study
Ethan Basch et al.
LANCET ONCOLOGY (2006)
Assessing health-related quality of life in palliative care: Comparing patient and physician assessments
MA Petersen et al.
EUROPEAN JOURNAL OF CANCER (2006)
How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30
EK Fromme et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Tolerability of hormone therapies for breast cancer: How informative are documented symptom profiles in medical notes for 'well-tolerated' treatments?
D Fellowes et al.
BREAST CANCER RESEARCH AND TREATMENT (2001)